Literature DB >> 28527781

Steroid metabolism in breast cancer: Where are we and what are we missing?

Donita Africander1, Karl-Heinz Storbeck2.   

Abstract

It is well-known that breast cancer is hormone-dependent and that steroid hormones exert their mitogenic effects by binding to estrogen, progesterone and androgen receptors. Vital to our understanding and treatment of this malignancy, is the local metabolism of steroid hormones in breast cancer tissue. This review summarises our current knowledge on steroid producing pathways in the adrenal, ovary and breast, while focussing on the availability of specific circulating hormone precursors and steroidogenic enzymes involved in the local synthesis and metabolism of steroid hormones in the breast. Consequently, we highlight alternate pathways that may be instrumental in the etiology of breast cancer.
Copyright © 2017 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Androgens; Breast cancer; Estrogens; Glucocorticoids; Intracrinology; Progestogens

Mesh:

Substances:

Year:  2017        PMID: 28527781     DOI: 10.1016/j.mce.2017.05.016

Source DB:  PubMed          Journal:  Mol Cell Endocrinol        ISSN: 0303-7207            Impact factor:   4.102


  16 in total

1.  Pre-treatment circulating reproductive hormones levels predict pathological and survival outcomes in breast cancer submitted to neoadjuvant chemotherapy.

Authors:  Ailin Lan; Yudi Jin; Yu Wang; Yihua Wang; Nan Ding; Yuran Dai; Linshan Jiang; Zhenrong Tang; Yang Peng; Shengchun Liu
Journal:  Int J Clin Oncol       Date:  2022-03-03       Impact factor: 3.402

2.  Steroidal ferrocenes as potential enzyme inhibitors of the estrogen biosynthesis.

Authors:  Bianka Edina Herman; János Gardi; János Julesz; Csaba Tömböly; Eszter Szánti-Pintér; Klaudia Fehér; Rita Skoda-Földes; Mihály Szécsi
Journal:  Biol Futur       Date:  2020-06-25

3.  Anticancer potential of β-sitosterol and oleanolic acid as through inhibition of human estrogenic 17beta-hydroxysteroid dehydrogenase type-1 based on an in silico approach.

Authors:  Alfinda Novi Kristanti; Nanik Siti Aminah; Imam Siswanto; Yosephine Sri Wulan Manuhara; Muhammad Ikhlas Abdjan; Andika Pramudya Wardana; Ei Ei Aung; Yoshiaki Takaya
Journal:  RSC Adv       Date:  2022-07-13       Impact factor: 4.036

Review 4.  The Divergent Function of Androgen Receptor in Breast Cancer; Analysis of Steroid Mediators and Tumor Intracrinology.

Authors:  Rachel Bleach; Marie McIlroy
Journal:  Front Endocrinol (Lausanne)       Date:  2018-10-26       Impact factor: 5.555

Review 5.  Breast Cancer: Targeting of Steroid Hormones in Cancerogenesis and Diagnostics.

Authors:  Marcela Valko-Rokytovská; Peter Očenáš; Aneta Salayová; Zuzana Kostecká
Journal:  Int J Mol Sci       Date:  2021-05-30       Impact factor: 5.923

6.  Antitumor Mechanisms of Curcumae Rhizoma Based on Network Pharmacology.

Authors:  Yan-Hua Bi; Li-Hua Zhang; Shao-Jun Chen; Qing-Zhi Ling
Journal:  Evid Based Complement Alternat Med       Date:  2018-02-05       Impact factor: 2.629

7.  Phase II Study of Dehydroepiandrosterone in Androgen Receptor-Positive Metastatic Breast Cancer.

Authors:  Elisabetta Pietri; Ilaria Massa; Sara Bravaccini; Sara Ravaioli; Maria Maddalena Tumedei; Elisabetta Petracci; Caterina Donati; Alessio Schirone; Federico Piacentini; Lorenzo Gianni; Mario Nicolini; Enrico Campadelli; Alessandra Gennari; Alessandro Saba; Beatrice Campi; Linda Valmorri; Daniele Andreis; Francesco Fabbri; Dino Amadori; Andrea Rocca
Journal:  Oncologist       Date:  2018-12-27

Review 8.  Intracrine androgen biosynthesis, metabolism and action revisited.

Authors:  Lina Schiffer; Wiebke Arlt; Karl-Heinz Storbeck
Journal:  Mol Cell Endocrinol       Date:  2017-09-01       Impact factor: 4.102

9.  The Preparation of Ginsenoside Rg5, Its Antitumor Activity against Breast Cancer Cells and Its Targeting of PI3K.

Authors:  Yannan Liu; Daidi Fan
Journal:  Nutrients       Date:  2020-01-18       Impact factor: 5.717

10.  Effects of doxorubicin associated with amniotic membrane stem cells in the treatment of canine inflammatory breast carcinoma (IPC-366) cells.

Authors:  Jéssica Borghesi; Sara Caceres; Lara Carolina Mario; Angela Alonso-Diez; Ana Carolina Silveira Rabelo; Maria J Illera; Gema Silvan; Maria Angélica Miglino; Phelipe O Favaron; Ana Claudia O Carreira; Juan Carlos Illera
Journal:  BMC Vet Res       Date:  2020-09-24       Impact factor: 2.741

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.